The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer
β Scribed by Claus Kamby; Birgitte Guldhammer; Ilse Vejborg; Niels Rossing; Hans Dirksen; Soeren Daugaard; H. T. Mouridsen
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 622 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Using cytokeratin (ck) as a histogenetic marker of epithelial tumor cells in the bone marrow of patients with primary breast carcinoma, a subgroup of patients with decreased survival can be identified. this study was designed to evaluate the frequency and prognostic relevance of such
## Abstract Immunocytochemical (ICC) detection of disseminated tumor cells (DTC) in bone marrow (BM) in early breast cancer is an independent prognostic factor. The significance of circulating tumor cells (CTC) in peripheral blood (PB) needs further exploration and comparison to DTC detection. PB a
BACKGROUND. β£-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH) closely follow the course of germ cell tumors (GCTs) and are widely used for diagnosis, prognosis, and follow-up purposes. The objective of this study was to assess the concordance of tumor markers a
The ability to identify cancer cells accurately by the simple technique of bone marrow aspiration is of great potential value, both clinically and in the investigation of many basic aspects of neoplastic disease. Previous workers have reported success in distinguishing exogeneous tumor cells from in